Form 483

Merck Serono SA Form 483, 2013-11-12

FDA issued a Form 483 to Merck Serono SA on 2013-11-12 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Merck Serono SA · Aubonne, Switzerland · Issued November 12, 2013

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Nov 2013
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Erika V Butler, Michael E Maselli

12 Nov 2013
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Erika V Butler, Michael E Maselli

12 Nov 2013
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Erika V Butler, Michael E Maselli

Inspected site

MSMerck Serono SAAubonne, Switzerland

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere